ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
ProPhase Labs's free cash flow for the twelve months ending Dec 31, 2025 was -$8.34M. For fiscal 2025 it was -$8.34M. The highest annual figure on record is $24.63M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.34M | – |
| FY2024 | Dec 31, 2024 | -$18.44M | – |
| FY2023 | Dec 31, 2023 | -$13.97M | -156.7% |
| FY2022 | Dec 31, 2022 | $24.63M | – |
| FY2021 | Dec 31, 2021 | -$17.85M | – |
| FY2020 | Dec 31, 2020 | -$4.28M | – |
| FY2019 | Dec 31, 2019 | -$1.07M | – |
| FY2018 | Dec 31, 2018 | -$2.26M | – |
| FY2017 | Dec 31, 2017 | -$3.05M | – |
| FY2016 | Dec 31, 2016 | -$1.12M | – |
| FY2015 | Dec 31, 2015 | -$4.22M | – |
| FY2014 | Dec 31, 2014 | -$3.53M | -607.6% |
| FY2013 | Dec 31, 2013 | $695.00K | – |
| FY2012 | Dec 31, 2012 | -$6.04M | – |
| FY2011 | Dec 31, 2011 | -$2.41M | – |
| FY2010 | Dec 31, 2010 | -$3.70M | -1662.0% |
| FY2009 | Dec 31, 2009 | $237.00K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$1.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.49M | – |
| Q2 FY2025 | Jun 30, 2025 | -$247.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.38M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.56M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.04M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.84M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$992.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.32M | -356.1% |
| Q2 FY2023 | Jun 30, 2023 | -$7.62M | -283.7% |
| Q1 FY2023 | Mar 31, 2023 | -$41.00K | -100.2% |
| Q4 FY2022 | Dec 31, 2022 | -$785.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $2.08M | – |
| Q2 FY2022 | Jun 30, 2022 | $4.15M | +0.4% |
| Q1 FY2022 | Mar 31, 2022 | $19.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.62M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.54M | – |
| Q2 FY2021 | Jun 30, 2021 | $4.13M | -4.8% |
| Q1 FY2021 | Mar 31, 2021 | -$11.82M | -7093.5% |
| Q4 FY2020 | Dec 31, 2020 | -$8.24M | – |
| Q3 FY2020 | Sep 30, 2020 | -$556.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $4.34M | – |
| Q1 FY2020 | Mar 31, 2020 | $169.00K | -87.5% |
| Q4 FY2019 | Dec 31, 2019 | -$471.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.00M | – |
| Q2 FY2019 | Jun 30, 2019 | -$952.00K | – |
| Q1 FY2019 | Mar 31, 2019 | $1.36M | – |
| Q4 FY2018 | Dec 31, 2018 | -$897.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.30M | -143.9% |
| Q4 FY2017 | Dec 31, 2017 | -$1.73M | -1143.4% |
| Q3 FY2017 | Sep 30, 2017 | -$515.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.76M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $166.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$774.00K | – |
See a number that looks wrong?